Please wait while the page is loading...

loader
 Archana Shanker

Archana Shanker

Senior Partner and Head of Department- Patents & Designs

Anand and Anand

India

FIRST CHANNEL BUILDING, PLOT NO 17A,
SECTOR 16A, FILMCITY
NOIDA
India

Telephone:

+91 120 4059300

E-mail Address:

archana@anandandanand.com

Archana Shanker

Areas of Expertise

Patents, IP Litigation, Pharma & Biotech

Overview

The first woman president of FICPI India, an advisory board member of IAM’s first-ever Women in Patents event and ranked amongst Managing IP’s Top 250 women in IP for eight consecutive years, Archana Shanker is regarded as a zealous patent practitioner setting new patent narratives in Indian IP jurisprudence while heading the Patents & Designs department at Anand and Anand.

Known for her unparalleled legal, scientific, and technical acumen, Archana is the go-to person for patent protection and enforcement, prosecution, pre-grant and post-grant oppositions, appeals, revocations, and plant variety protection as she manages an extensive portfolio of patents.

A leading voice advocating the cause of women in IP, Archana heads a team of lawyers-cum-scientists, engineers, biotechnologists, chemists, and physicists – advising extensively in adversarial proceedings. In 35-plus years of dedicated practice across industries from pharmaceuticals to life sciences, software, ICT, telecom, mechanical, electronics and biodiversity, Archana has earned a solid reputation not just in patents but in the larger IP sphere globally.

She has been a lead in cases returning noteworthy judgments like Monsanto’s Supreme Court order, the Ferid Allani case, Pioneer Overseas Corporation, Novo Nordisk, Roche, Merck, Sterlite, etc.

Domestic and international clients alike trust her understanding of the key drivers of the industry and the science behind them. Business-minded, cost-conscious and a thought leader, Archana is ever-ready to take challenges head-on and shift paradigms. 

 

Articles

Can you protect your IP with an NDA?

Can you protect your IP w...

“Prevention is better than cure,” and it is always beneficia...

More
Success Story Turns Bleak for Compulsory License: A Report

Success Story Turns Bleak...

What are the compulsory license proceedings of Lee Pharma fo...

More